Bio View

Bio View Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Bio View (BIOV.TA) as of Oct 19, 2026 is 1.42. In the previous year, Net Debt to Free Cash Flow Ratio was 2.85 — a change of -50.10% (lower).

Net Debt/FCF

1.42

YoY

-50.10%

Last updated:

Net Debt to Free Cash Flow Ratio of Bio View is 2025 1.42 . Net Debt to Free Cash Flow Ratio of Bio View was 2024 2.85 . It decreases by -50.10% lower compared to the previous year.

The Bio View Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2019
-7.10 ILS
Jan 1, 2020
-31.68 ILS
Jan 1, 2021
-5.65 ILS
Jan 1, 2022
-30.10 ILS
Jan 1, 2023
112.46 ILS
Jan 1, 2024
2.85 ILS
Jan 1, 2025
1.42 ILS
The Bio View Net Debt/FCF history
YEARNet Debt/FCFYoY
1.42-50.10%
2.85-97.46%
112.46-473.68%
-30.10+432.93%
-5.65-82.17%
-31.68+345.95%
-7.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Net Debt to Free Cash Flow Ratio of Bio View is 1.42 in 2025.

Net Debt to Free Cash Flow Ratio of Bio View changed from 2.85 to 1.42, representing a -50.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Bio View since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Bio View with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Bio View

All Key Metrics — Bio View